Innovative Approaches to NAFLD : Exploring the Role of Nicotinamide in Multicellular Microtissue Models of Liver Fibrosis
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70606 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Farnaz Sani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shiraz Institute for Stem Cell & Regenerative Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. Hauptthemen laut MEDLINE: Niacinamide, Non-alcoholic Fatty Liver Disease, Liver Cirrhosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Medical Research Development (NIMAD).
Abstract (Originalsprache)
In non‐alcoholic fatty liver disease (NAFLD), characterised by progressive liver damage, inflammation, fibrosis and potential cirrhosis, treatment options are limited, with liver transplantation as the only definitive solution. To address this urgent need, in vitro and tissue engineering studies have explored new drugs. This study investigated the anti‐inflammatory and anti‐fibrotic potential of Nicotinamide, utilising promising preliminary data for treating NAFLD. Multicellular liver microtissues comprising LX2 stellate cells, HepG2 hepatocytes and HUVECs were generated to establish a robust preclinical model for fibrosis. Cell viability and histological assessments confirmed successful co‐aggregation within the microtissues. To induce fibrosis, they were treated with a palmitic and oleic acid mixture, followed by exposure to Nicotinamide. Treatment effectiveness was evaluated by analysing inflammatory factors, including transforming growth factor β1 (TGF‐β1), tumour necrosis factor‐alpha (TNF‐α) and interleukin 1 beta and interleukin 6. Extracellular matrix deposition was assessed by measuring collagen type I (COL I) and α‐smooth muscle actin (α‐SMA). Our data suggested that Nicotinamide application led to significant improvements across several measures. Specifically, it effectively reduced inflammatory response by reducing TGF‐β1 levels and decreasing COL I and α‐SMA levels. Furthermore, Nicotinamide was crucial in reducing reactive oxygen species levels, indicating that activation of HSC, inflammatory signals and oxidative stress work together. These in vitro findings suggest Nicotinamide may have therapeutic potential warranting further investigation in advanced preclinical models. Our findings demonstrated significant improvements across various parameters, including reduced expression of pro‐inflammatory cytokines and attenuated oxidative stress, underscoring the therapeutic potential of Nicotinamide in clinical studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shiraz Institute for Stem Cell & Regenerative Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
- Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston Salem, North Carolina, USA.
- Zoonoses Research Center, Jahrom University of Medical Sciences, Jahrom, Iran.
- Department of Pathology, School of Medicine, Jahrom University of Medical Sciences, Jahrom, Iran.
- Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
- Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
ORCID-Profile: Farnaz Sani, Mahsa Sani
Förderung
- National Institute for Medical Research Development (NIMAD)
Zitieren
APA
Sani, F., Parsa, S., Falamarzi, K., Khorraminejad-Shirazi, M., Azarpira, N., & Sani, M. (2025). Innovative Approaches to NAFLD : Exploring the Role of Nicotinamide in Multicellular Microtissue Models of Liver Fibrosis. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70606
Vancouver
Sani F, Parsa S, Falamarzi K, Khorraminejad-Shirazi M, Azarpira N, Sani M. Innovative Approaches to NAFLD : Exploring the Role of Nicotinamide in Multicellular Microtissue Models of Liver Fibrosis. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70606
BibTeX
@article{Sani2025,
author = {Sani, Farnaz and Parsa, Shima and Falamarzi, Kimia and Khorraminejad-Shirazi, Mohammadhossein and Azarpira, Negar and Sani, Mahsa},
title = {Innovative Approaches to NAFLD : Exploring the Role of Nicotinamide in Multicellular Microtissue Models of Liver Fibrosis},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70606}
}
EUVIMED